Quantum's in the name but has no part of the business. Quantum BioPharma (QNTM) is up over 130% year to date but has fallen more than 50% off its all-time high. George Tsilis notes the interesting drugs it's developing can reach corners of the market sometimes ignored. The issue? Quantum's lack of revenue, which George says needs to reverse for these products to get on shelves.